Anti-Tumor Immunity Effect of Immune Checkpoint Inhibitors in Neuroblastoma Model

被引：0

作者：

Saito, Takeshi ^{[1
]}

Fuchimoto, Yasushi ^{[2
,3
]}

Kuroda, Tatsuo ^{[4
]}

Hirabayashi, Takeshi ^{[1
]}

Hakamada, Kenichi ^{[1
]}

机构：

[1] Hirosaki Univ Hosp, Dept Pediat Surg, Hirosaki, Aomori, Japan

[2] Int Univ Hlth, Dept Pediat Surg, Otawara, Japan

[3] Welf Sch Med, Otawara, Japan

[4] Keio Univ, Dept Pediat Surg, Sch Med, Keio, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2021年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS23-3

引用

页数：1

共 50 条

[31] The HDAC inhibitor belinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors in a murine hepatocellular carcinoma model [J].

Llopiz, D. ;

Ruiz, M. ;

Villanueva, L. ;

Iglesias, T. ;

Lasarte, J. J. ;

Pivette, P. ;

Trocon-Joseph, V. ;

Vasseur, B. ;

Dixon, G. ;

Sangro, B. ;

Sarobe, P. .

JOURNAL OF HEPATOLOGY, 2018, 68 :S677-S677

[32] Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now? [J].

Valind, Anders ;

Gisselsson, David .

CANCER REPORTS, 2021, 4 (06)

[33] Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors [J].

Arciga, Blake M. ;

Walters, Dustin M. ;

Kimchi, Eric T. ;

Staveley-O'Carroll, Kevin F. ;

Li, Guangfu ;

Teixeiro, Emma ;

Rachagani, Satyanarayana ;

Kaifi, Jussuf T. .

CANCER LETTERS, 2025, 609

[34] Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors [J].

Liang, Ying ;

Wang, Lingling ;

Ma, Peijun ;

Ju, Dongen ;

Zhao, Minggao ;

Shi, Yun .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[35] Tumor antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers [J].

Ueda, S. ;

Ushijima, M. ;

Irie, A. ;

Senju, S. ;

Ito, K. ;

Hamana, H. ;

Kishi, H. ;

Ogasawara, K. ;

Udaka, K. ;

Nishimura, Y. ;

Eto, M. .

EUROPEAN UROLOGY, 2023, 83

[36] Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy [J].

Andersson, Patrik ;

Ostheimer, Christian .

FRONTIERS IN IMMUNOLOGY, 2019, 10

[37] Brachytherapy dose heterogeneity primes response to immune checkpoint blockade to generate anti-tumor immunity [J].

Jagodinsky, Justin C. ;

Jin, Wonjong ;

Vera, Jessica M. ;

Sriramaneni, Raghava N. ;

Clark, Paul A. ;

Lan, Keng-Hsueh S. ;

Chakravarty, Ishan ;

Siegel, Noah ;

Allawi, Raad H. ;

Emma, Sarah E. ;

Arthur, Ian S. ;

Das, Rupak K. ;

Ong, Irene M. ;

Miller, Jessica R. ;

Morris, Zachary S. .

CANCER RESEARCH, 2022, 82 (12)

[38] TUMOR ANTIGEN VACCINE ENHANCES ANTI-TUMOR EFFECTS OF IMMUNE CHECKPOINT INHIBITORS AGAINST REFRACTORY CANCERS [J].

Ueda, Shohei ;

Ushjima, Miho ;

Irie, Atsushi ;

Nishimura, Yasuharu ;

Eto, Masatoshi .

JOURNAL OF UROLOGY, 2022, 207 (05) :E199-E200

[39] Anti-tumor immunity and tumor anti-immunity in a mathematical model of tumor immunotherapy [J].

Forys, U ;

Waniewski, J ;

Zhivkov, P .

JOURNAL OF BIOLOGICAL SYSTEMS, 2006, 14 (01) :13-30

[40] Tumor cell-derived lactic acid inhibit anti-tumor immunity in the immune checkpoint blockade resistant tumor [J].

Oh, Wonkyung ;

Kim, Alyssa Min Jung ;

Sun, Ruoxuan ;

Lim, Seung-Oe .

CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)

← 1 2 3 4 5 →